| Introduction |
The RNA targeting small molecule therapies market is projected to be worth around USD 8.3 billion in 2030
In the recent years, RNA’s potential as a target molecule for small molecules has been widely recognized; as a result, a number of industry players have developed their proprietary technologies for direct and indirect RNA targeting and are actively engaged in the discovery and development of therapies against a wide range of therapeutic disorder
|